News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
368,959 Results
Type
Article (17733)
Company Profile (31)
Press Release (351195)
Multimedia
Podcasts (19)
Webinars (7)
Section
Business (117579)
Career Advice (939)
Deals (21154)
Drug Delivery (51)
Drug Development (41896)
Employer Resources (78)
FDA (7204)
Job Trends (7135)
News (189099)
Policy (14727)
Tag
2024 BioCapital Digital (2)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (2)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1165)
Accelerated approval (2)
Adcomms (7)
Allergies (35)
Alliances (22281)
ALS (38)
Alzheimer's disease (568)
Antibody-drug conjugate (ADC) (47)
Approvals (7228)
Artificial intelligence (84)
Autoimmune disease (11)
Automation (7)
Bankruptcy (165)
Best Places to Work (5700)
BIOSECURE Act (13)
Biosimilars (27)
Biotechnology (28)
Bladder cancer (33)
Brain cancer (14)
Breast cancer (117)
Cancer (1024)
Cardiovascular disease (80)
Career advice (814)
Career pathing (7)
CAR-T (69)
Cell therapy (208)
Cervical cancer (9)
Clinical research (34225)
Collaboration (315)
Compensation (184)
Complete response letters (7)
COVID-19 (993)
CRISPR (17)
C-suite (148)
Cystic fibrosis (45)
Data (1127)
Decentralized trials (2)
Denatured (2)
Depression (14)
Diabetes (133)
Diagnostics (3487)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (27)
Drug discovery (46)
Drug pricing (49)
Drug shortages (10)
Duchenne muscular dystrophy (44)
Earnings (53423)
Editorial (22)
Employer branding (10)
Employer resources (73)
Events (62082)
Executive appointments (487)
FDA (7718)
Featured Employer (12)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (346)
Gene editing (43)
Generative AI (4)
Gene therapy (132)
GLP-1 (326)
Government (1752)
Grass and pollen (2)
Guidances (25)
Healthcare (10519)
Huntington's disease (4)
IgA nephropathy (15)
Immunology and inflammation (45)
Indications (13)
Infectious disease (1045)
Inflammatory bowel disease (76)
Inflation Reduction Act (6)
Influenza (20)
Intellectual property (43)
Interviews (114)
IPO (10271)
IRA (19)
Job creations (1609)
Job search strategy (736)
Kidney cancer (9)
Labor market (11)
Layoffs (172)
Leadership (8)
Legal (3738)
Liver cancer (30)
Lung cancer (134)
Lymphoma (79)
Machine learning (1)
Management (27)
Manufacturing (118)
MASH (47)
Medical device (6805)
Medtech (6807)
Mergers & acquisitions (11232)
Metabolic disorders (310)
Multiple sclerosis (20)
NASH (7)
Neurodegenerative disease (31)
Neuropsychiatric disorders (5)
Neuroscience (769)
NextGen: Class of 2025 (3357)
Non-profit (2533)
Northern California (1372)
Now hiring (4)
Obesity (145)
Opinion (105)
Ovarian cancer (34)
Pain (43)
Pancreatic cancer (44)
Parkinson's disease (63)
Partnered (8)
Patents (77)
Patient recruitment (54)
Peanut (19)
People (37621)
Pharmaceutical (14)
Pharmacy benefit managers (11)
Phase I (10280)
Phase II (14683)
Phase III (11856)
Pipeline (734)
Policy (69)
Postmarket research (1587)
Preclinical (4585)
Press Release (68)
Prostate cancer (57)
Psychedelics (10)
Radiopharmaceuticals (163)
Rare diseases (172)
Real estate (2681)
Recruiting (28)
Regulatory (10132)
Reports (24)
Research institute (960)
Resumes & cover letters (123)
Rett syndrome (3)
RSV (10)
Schizophrenia (35)
Series A (62)
Series B (35)
Service/supplier (1)
Sickle cell disease (32)
Southern California (1138)
Special edition (6)
Spinal muscular atrophy (58)
Sponsored (12)
Startups (1608)
State (1)
Stomach cancer (2)
Supply chain (30)
Tariffs (5)
The Weekly (17)
United States (11531)
Vaccines (218)
Venture capitalists (12)
Weight loss (84)
Women's health (13)
Worklife (5)
Date
Today (35)
Last 7 days (241)
Last 30 days (1387)
Last 365 days (17885)
2025 (4709)
2024 (19483)
2023 (22437)
2022 (29615)
2021 (31266)
2020 (29477)
2019 (24631)
2018 (18773)
2017 (16925)
2016 (16418)
2015 (19872)
2014 (15523)
2013 (12456)
2012 (13389)
2011 (14284)
2010 (13739)
Location
Africa (349)
Alabama (36)
Alaska (5)
Arizona (96)
Arkansas (8)
Asia (20007)
Australia (3101)
California (2992)
Canada (1112)
China (224)
Colorado (143)
Connecticut (160)
Delaware (59)
Europe (42810)
Florida (492)
Georgia (99)
Idaho (28)
Illinois (249)
India (12)
Indiana (170)
Iowa (1)
Japan (94)
Kansas (45)
Kentucky (16)
Louisiana (7)
Maine (46)
Maryland (434)
Massachusetts (2293)
Michigan (126)
Minnesota (217)
Mississippi (2)
Missouri (45)
Montana (26)
Nebraska (15)
Nevada (42)
New Hampshire (30)
New Jersey (1041)
New Mexico (14)
New York (763)
North Carolina (553)
North Dakota (4)
Northern California (1372)
Ohio (108)
Oklahoma (8)
Oregon (9)
Pennsylvania (594)
Puerto Rico (5)
Rhode Island (15)
South America (575)
South Carolina (11)
Southern California (1138)
Tennessee (58)
Texas (401)
Utah (89)
Virginia (65)
Washington D.C. (36)
Washington State (249)
West Virginia (2)
Wisconsin (28)
368,959 Results for "american diversified holdings corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
March 13, 2025
·
28 min read
Press Releases
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
March 5, 2025
·
14 min read
Press Releases
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session
March 26, 2025
·
6 min read
Policy
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
Scorpius Holdings, Inc reported that it received notice from the NYSE American of its determination to commence delisting proceedings of the Company’s common stock from the exchange pursuant to Section 1003 of the NYSE American Company Guide due to the low-selling price of the Company’s common stock.
June 17, 2024
·
2 min read
Press Releases
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
March 5, 2025
·
9 min read
Lone Star Bio
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting
Bio-Path Holdings, Inc. announced an upcoming oral presentation at the American Society of Clinical Oncology Annual Meeting, taking place May 31 - June 4, 2024 in Chicago, IL.
May 23, 2024
·
4 min read
Press Releases
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo
April 2, 2025
·
4 min read
BioCapital
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
Senseonics Holdings, Inc. announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.
June 13, 2024
·
1 min read
Press Releases
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
March 5, 2025
·
12 min read
Biotech Bay
Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024
Scilex Holding Company announced it will be presenting a poster on ELYXYB® at the 66th Annual Scientific Meeting of the American Headache Society to be held in San Diego, CA on June 13-16, 2024.
June 13, 2024
·
7 min read
1 of 36,896
Next
